Combined with insights gained from inhibiting the PLCγ1 pathway in the ATLL cell lineage, these findings underscore the critical role of mutated PLCγ1 activation in ATLL pathology. This evidence concerns the gene PLCG1 and adult T-cell leukemia/lymphoma.